Page 136 - 2021 IDMT Digital
P. 136
NASAL POLYPS
Introduction:
• 1DVDO SRO\SV DUH SDOH HGHPDWRXV PXFRVDOO\ FRYHUHG PDVVHV FRPPRQO\ VHHQ LQ
SDWLHQWV ZLWK DOOHUJLF UKLQLWLV
o 7KH\ PD\ UHVXOW LQ FKURQLF QDVDO REVWUXFWLRQ DQG GLPLQLVKHG VHQVH RI VPHOO
• 3DWLHQWV ZLWK QDVDO SRO\SV DQG KLVWRU\ RI DVWKPD VKRXOG QRW WDNH DVSLULQ DV LW PD\
SUHFLSLWDWH VHYHUH EURQFKRVSDVP 6DPWHU¶V WULDG
Subjective:
• 6LJQV DQG 6\PSWRPV
o 1DVDO FRQJHVWLRQ RU REVWUXFWLRQ
o 'LPLQLVKHG VHQVH RI VPHOO
o 6\PSWRPV RI DOOHUJLF UKLQLWLV
Objective:
• 3K\VLFDO ([DP
o (YDOXDWH WKH QDVDO FDYLW\ IRU SDWHQF\ GLVFKDUJH DQG REYLRXV PDVVHV
Assessment:
• 'LIIHUHQWLDO
o ,QYHUWHG SDSLOORPD FDXOLIORZHU OLNH JURZWK +39
o 0DOLJQDQW WXPRU H[SDQVLRQ RI WKH FKHHN DQG SURSWRVLV
o 7XUELQDWH K\SHUWURSK\ HQODUJHG ERJJ\ WXUELQDWHV
Plan:
• 7RSLFDO QDVDO FRUWLFRVWHURLGV
o ,QLWLDO WUHDWPHQW DQG PXVW EH XVHG IRU PRQWKV WR VHH UHGXFWLRQ
)OXWLFDVRQH PRPHWDVRQH
o :KHQ SRO\SV DUH PDVVLYH RU PHGLFDO PDQDJHPHQW LV XQVXFFHVVIXO (17 VXUJHU\
PD\ EH QHFHVVDU\
Patient Education:
• )ROORZ XS $FWLRQV
o 5HWXUQ IRU IXUWKHU HYDOXDWLRQ LI PHGLFDWLRQ LV QRW KHOSLQJ ZLWKLQ PRQWKV RU LI
QDVDO REVWUXFWLRQ RFFXUV
Preceptor Directive:
• Green Directive: Routine Review by Preceptor IAW AFI 44-103
[ 135 ]
